135 related articles for article (PubMed ID: 377994)
1. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis.
Awai M; Narasaki M; Yamanoi Y; Seno S
Am J Pathol; 1979 Jun; 95(3):663-73. PubMed ID: 377994
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis and mechanism of iron overload: ferric nitrilotriacetate, hemosiderin, active oxygen, and carcinogenesis].
Awai M
Rinsho Ketsueki; 1989 Aug; 30(8):1115-27. PubMed ID: 2689676
[TBL] [Abstract][Full Text] [Related]
3. Iron nitrilotriacetate--induced experimental diabetes in rats.
May ME; Parmley RT; Spicer SS; Ravenel DP; May EE; Buse MG
J Lab Clin Med; 1980 Apr; 95(4):525-35. PubMed ID: 6987319
[TBL] [Abstract][Full Text] [Related]
4. Experimental iron overload using ferric nitrilotriacetate (Fe3+-NTA): a proposal model of the diseases in man caused by iron overload.
Awai M
Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1650-9. PubMed ID: 3564852
[No Abstract] [Full Text] [Related]
5. Renal impairment in experimental hemochromatosis in rats.
May ME; May EE; Parmley RT; Spicer SS; Buse MG
Horm Metab Res; 1983 Apr; 15(4):194-6. PubMed ID: 6862358
[TBL] [Abstract][Full Text] [Related]
6. Degranulation effect of ferric nitrilotriacetate (Fe3+-NTA) on the pancreatic islet beta-cells: its acute toxic effect on glucose metabolism.
Yamanoi Y; Awai M; Seno S
Acta Med Okayama; 1984 Oct; 38(5):423-37. PubMed ID: 6393716
[TBL] [Abstract][Full Text] [Related]
7. [Induction, characterization and isolation of preneoplastic hepatocytes following combined treatment with 2-acetaminofluorene and ferric nitrilotriacetate].
Bibbiani C; Malvaldi G
Boll Soc Ital Biol Sper; 1981 Aug; 57(16):1722-6. PubMed ID: 6118169
[TBL] [Abstract][Full Text] [Related]
8. Tissue iron loading and histopathological changes in hypotransferrinaemic mice.
Simpson RJ; Konijn AM; Lombard M; Raja KB; Salisbury JR; Peters TJ
J Pathol; 1993 Nov; 171(3):237-44. PubMed ID: 8277372
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islets after repeated injection of Fe3+-NTA. An ultrastructural study of diabetic rats.
Shirasuga N; Hayashi K; Awai M
Acta Pathol Jpn; 1989 Mar; 39(3):159-68. PubMed ID: 2662704
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats.
Anwer T; Sharma M; Pillai KK; Haque SE; Alam MM; Zaman MS
Toxicology; 2007 Jan; 229(1-2):165-72. PubMed ID: 17145126
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of islet tissue in the rat.
Hegre OD; Leonard RJ; Erlandsen SL; McEvoy RC; Parsons JA; Elde RP; Lazarow A
Acta Endocrinol Suppl (Copenh); 1976; 205():257-81. PubMed ID: 826063
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
13. The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induced diabetic rat.
Howarth FC; Marzouqi FM; Al Saeedi AM; Hameed RS; Adeghate E
JOP; 2009 Sep; 10(5):485-91. PubMed ID: 19734622
[TBL] [Abstract][Full Text] [Related]
14. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats].
He QH; Zhou YS; Wang Z; Wang S; Mou ZQ; Li J; Chi JM
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):374-7. PubMed ID: 18581888
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of iron toxicity in the liver and pancreas after a single injection of ferric nitrilotriacetate.
Yamanoi Y; Matsuura R; Awai M
Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1229-35. PubMed ID: 7168306
[No Abstract] [Full Text] [Related]
16. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats.
Ebina Y; Okada S; Hamazaki S; Ogino F; Li JL; Midorikawa O
J Natl Cancer Inst; 1986 Jan; 76(1):107-13. PubMed ID: 3455733
[TBL] [Abstract][Full Text] [Related]
17. Hepatic and pancreatic effects of polyenoylphosphatidylcholine in rats with alloxan-induced diabetes.
Buko V; Lukivskaya O; Nikitin V; Tarasov Y; Zavodnik L; Borodinsky A; Gorenshtein B; Janz B; Gundermann KJ; Schumacher R
Cell Biochem Funct; 1996 Jun; 14(2):131-7. PubMed ID: 8640953
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
Reimers JI
Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
[TBL] [Abstract][Full Text] [Related]
19. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
[TBL] [Abstract][Full Text] [Related]
20. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
